{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T05:23:10Z","timestamp":1692422590732},"reference-count":42,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.humpath.2008.05.011","type":"journal-article","created":{"date-parts":[[2008,8,21]],"date-time":"2008-08-21T12:00:43Z","timestamp":1219320043000},"page":"1728-1736","source":"Crossref","is-referenced-by-count":5,"title":["KIT codon 558 insertions in gastrointestinal stromal tumors. Analysis of 17 rare KIT mutants"],"prefix":"10.1016","volume":"39","author":[{"given":"Jerzy","family":"Lasota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Kuban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Wardelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Debiec-Rychter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Merkelbach-Bruse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raf","family":"Sciot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janusz","family":"Rys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja E.","family":"Steigen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Iwanik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph A.","family":"Holden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Jerzak vel Dobosz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Ulrich","family":"Schildhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markku","family":"Miettinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2008.05.011_bib1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.semdp.2006.09.001","article-title":"Pathology and prognosis of gastrointestinal stromal tumors at different sites","volume":"23","author":"Miettinen","year":"2006","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.humpath.2008.05.011_bib2","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1007\/s00018-004-4273-y","article-title":"Kit as human oncogenic tyrosine kinase","volume":"61","author":"Kitamura","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.humpath.2008.05.011_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/(SICI)1097-0029(19991115)47:4<239::AID-JEMT3>3.0.CO;2-0","article-title":"Gastrointestinal peristalsis: joint action of enteric nerves, smooth muscle, and interstitial cells of Cajal","volume":"47","author":"Huizinga","year":"1999","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.humpath.2008.05.011_bib4","first-page":"1259","article-title":"Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal","volume":"152","author":"Kindblom","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2008.05.011_bib5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0959-8049(02)80597-4","article-title":"Regulation and targets of receptor tyrosine kinases","volume":"38","author":"Pawson","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.humpath.2008.05.011_bib6","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","article-title":"Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors","volume":"279","author":"Hirota","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.humpath.2008.05.011_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.semdp.2006.08.006","article-title":"KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs)","volume":"23","author":"Lasota","year":"2006","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.humpath.2008.05.011_bib8","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1126\/science.1079666","article-title":"PDGFRA activating mutations in gastrointestinal stromal tumors","volume":"299","author":"Heinrich","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.humpath.2008.05.011_bib9","first-page":"4297","article-title":"Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors","volume":"59","author":"Taniguchi","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2008.05.011_bib10","first-page":"8118","article-title":"KIT activation is a ubiquitous feature of gastrointestinal stromal tumors","volume":"61","author":"Rubin","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2008.05.011_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0002-9440(10)64343-X","article-title":"The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker cell) tumors","volume":"160","author":"Andersson","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2008.05.011_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/modpathol.3880504","article-title":"c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant","volume":"15","author":"Wardelmann","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2008.05.011_bib13","first-page":"3329","article-title":"Association of KIT exon 9 mutation with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors","volume":"9","author":"Antonescu","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2008.05.011_bib14","doi-asserted-by":"crossref","first-page":"7780","DOI":"10.1038\/sj.onc.1208056","article-title":"Gastrointestinal stromal tumors (GISTs) wit KIT and PDGFRA mutations have distinct gene expression profiles","volume":"23","author":"Subramanian","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2008.05.011_bib15","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1158\/1078-0432.CCR-04-2245","article-title":"Acquired resistance to imatinib in gastrointestinal stromal tumors occurs through secondary gene mutation","volume":"11","author":"Antonescu","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2008.05.011_bib16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/jcp.2004.024364","article-title":"The value of c-kit mutational analysis in a cytokeratin positive gastrointestinal stromal tumour","volume":"58","author":"Rossi","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2008.05.011_bib17","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1200\/JCO.2006.06.2265","article-title":"Molecular correlates of imatinib resistance in gastrointestinal stromal tumors","volume":"24","author":"Heinrich","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2008.05.011_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0463.2007.apm_587.x","article-title":"Mutations in gastrointestinal stromal tumors\u2014a population-based study from Northern Norway","volume":"115","author":"Steigen","year":"2007","journal-title":"APMIS"},{"key":"10.1016\/j.humpath.2008.05.011_bib19","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.3748\/wjg.14.1891","article-title":"KIT exon 11 codon 557\/558 deletion\/insertion mutations define a subset of gastrointestinal stromal tumors with malignant potential","volume":"14","author":"Kontogianni-Katsarou","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.humpath.2008.05.011_bib20","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/01.MP.0000097365.72526.3E","article-title":"Gastrointestinal stromal tumors with internal tandem duplications in 3\u2032 end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course","volume":"16","author":"Lasota","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2008.05.011_bib21","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0046-8177(03)00407-6","article-title":"KIT 1530ins6 mutation defines a subset of predominantly malignant gastrointestinal stromal tumors of intestinal origin","volume":"34","author":"Lasota","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2008.05.011_bib22","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/labinvest.3700122","article-title":"A great majority of GISTs with PDGFRA mutations represents gastric tumors of low or no malignant potential","volume":"84","author":"Lasota","year":"2004","journal-title":"Lab Invest"},{"key":"10.1016\/j.humpath.2008.05.011_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1525-1578(10)60510-7","article-title":"Association of platelet-derived growth factor receptor \u03b1 mutations with gastric primary site and epithelioid or mixed cell morphology in gastrointestinal stromal tumors","volume":"6","author":"Wardelmann","year":"2004","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.humpath.2008.05.011_bib24","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/modpathol.3800136","article-title":"Differential expression of KIT\/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site","volume":"17","author":"Wasag","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2008.05.011_bib25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.pas.0000146010.92933.de","article-title":"Gastrointestinal stromal tumors (GISTs) of the stomach\u2014a clinicopathologic, immunohistochemical and molecular genetic study of 1756 cases with long-term follow-up","volume":"29","author":"Miettinen","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2008.05.011_bib26","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00000478-200604000-00008","article-title":"Gastrointestinal stromal tumors (GISTs) of the jejunum and ileum: a clinicopathologic, immunohistochemical and molecular genetic study of 906 cases before imatinib with long-term follow-up","volume":"30","author":"Miettinen","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2008.05.011_bib27","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1034\/j.1600-0463.2002.100608.x","article-title":"Patterns of nestin and other intermediate filament expression distinguish between gastrointestinal stromal tumors, leiomyomas and schwannomas","volume":"110","author":"Sarlomo-Rikala","year":"2002","journal-title":"APMIS"},{"key":"10.1016\/j.humpath.2008.05.011_bib28","doi-asserted-by":"crossref","first-page":"W577","DOI":"10.1093\/nar\/gki591","article-title":"DINAMelt web server for nucleic acid melting prediction","volume":"33","author":"Markham","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.humpath.2008.05.011_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cancergencyto.2006.12.010","article-title":"KIT exon 11 deletion-inversions represent complex mutations in gastrointestinal stromal tumors","volume":"175","author":"Lasota","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.humpath.2008.05.011_bib30","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1038\/sj.onc.1204704","article-title":"STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications","volume":"20","author":"Tuveson","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2008.05.011_bib31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev.genet.36.042602.094806","article-title":"Origins of spontaneous mutations: specificity and directionality of base-substitution, frameshift, and sequence-substitution mutageneses","volume":"36","author":"Maki","year":"2002","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.humpath.2008.05.011_bib32","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1128\/MCB.17.9.5559","article-title":"Palindrome resolution and recombination in the mammalian germ line","volume":"17","author":"Akg\u00fcn","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.humpath.2008.05.011_bib33","series-title":"In Genetic recombination","first-page":"621","article-title":"Illegitimate recombination in mammalian cells","author":"Roth","year":"1988"},{"key":"10.1016\/j.humpath.2008.05.011_bib34","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1053\/j.gastro.2006.01.043","article-title":"Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis","volume":"130","author":"Andersson","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humpath.2008.05.011_bib35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/01.pas.0000213307.05811.f0","article-title":"Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations","volume":"31","author":"Agaimy","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2008.05.011_bib36","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/ijc.11323","article-title":"Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors","volume":"106","author":"Wardelmann","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2008.05.011_bib37","doi-asserted-by":"crossref","first-page":"6190","DOI":"10.1200\/JCO.2005.19.554","article-title":"Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS)","volume":"23","author":"Martin","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2008.05.011_bib38","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM200104053441404","article-title":"Effect of tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor","volume":"344","author":"Joensuu","year":"2001","journal-title":"N Engl J Med"},{"issue":"Suppl 5","key":"10.1016\/j.humpath.2008.05.011_bib39","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/S0959-8049(02)80603-7","article-title":"Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571)","volume":"38","author":"Demetri","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.humpath.2008.05.011_bib40","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1200\/JCO.2003.04.190","article-title":"Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor","volume":"21","author":"Heinrich","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2008.05.011_bib41","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.ejca.2006.01.030","article-title":"KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumors","volume":"42","author":"Debiec-Rychter","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.humpath.2008.05.011_bib42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/labinvest.3700524","article-title":"Juxtamembrane-type c-kit gene mutation found in aggressive systematic mastocytosis induces imatinib-resistant constitutive KIT activation","volume":"87","author":"Nakagomi","year":"2007","journal-title":"Lab Invest"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817708002323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817708002323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T14:01:25Z","timestamp":1557756085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817708002323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0046817708002323"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2008.05.011","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}